Randomized Double-Blind Placebo-Controlled Phase 2 Study of Bemarituzumab Combined with Modified Folfox6 (Mfolfox6) in First-Line (1L) Treatment of Advanced Gastric/Gastroesophageal Junction Adenocarcinoma (Fight).

AuthID
 P-00T-SFF
16
Author(s)
Wainberg, ZA
·
Enzinger, PC
·
Kang, YK
·
Yamaguchi, K
·
Qin, SK
·
Lee, KW
·
Oh, SC
·
Li, J
·
Turk, HM
·
Teixeira, AC
·
Cardellino, GG
·
Guardeno, R
·
Mitra, S
·
Yang, YS
·
Collins, H
·
Tipo de Documento
Abstract
Year published
2021
Publicado
in JOURNAL OF CLINICAL ONCOLOGY, ISSN: 0732-183X
Volume: 39, Número: 3
Indexing
Wos®
Google Scholar®
Publication Identifiers
Wos: WOS:000636712800195
Source Identifiers
ISSN: 0732-183X
Export Publication Metadata
Lista Marked
 Adicionar à lista Marked
Citações
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

CORE Conference
No information about CORE Rank

During the preprocessing phase, only publications of type 'Proceedings Paper' or 'Proceedings' are automatically processed to identify their CORE Rank.

TIP: If your publication's CORE Rank is missing, you can contact with your institutional manager to have the correct ranking manually added to the record.

Journal Factors
Oops! It looks like you don't have access to this content.

This section is restricted to uses with b-on access.

Info
At this moment we don't have any links to full text documens.

Um espaço para investigadores e suas Instituições

Links Úteis

Ajuda

© 2026 CRACS & Inesc TEC - All Rights Reserved Política de Privacidade | Terms of Service